RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.
The Franklin, Tennessee-based operator has not purchased a hospital in years. That may soon change as CHS' margins improve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback